Your browser doesn't support javascript.
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.
Seaman, Michael S; Siedner, Mark J; Boucau, Julie; Lavine, Christy L; Ghantous, Fadi; Liew, May Y; Mathews, Josh I; Singh, Arshdeep; Marino, Caitlin; Regan, James; Uddin, Rockib; Choudhary, Manish C; Flynn, James P; Chen, Geoffrey; Stuckwisch, Ashley M; Lipiner, Taryn; Kittilson, Autumn; Melberg, Meghan; Gilbert, Rebecca F; Reynolds, Zahra; Iyer, Surabhi L; Chamberlin, Grace C; Vyas, Tammy D; Vyas, Jatin M; Goldberg, Marcia B; Luban, Jeremy; Li, Jonathan Z; Barczak, Amy K; Lemieux, Jacob E.
  • Seaman MS; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Siedner MJ; Harvard Medical School, Boston, Massachusetts, USA.
  • Boucau J; Harvard Medical School, Boston, Massachusetts, USA.
  • Lavine CL; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Ghantous F; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
  • Liew MY; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Mathews JI; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Singh A; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Marino C; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Regan J; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Uddin R; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
  • Choudhary MC; Brigham and Women's Hospital Boston, Massachusetts, USA.
  • Flynn JP; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Chen G; Brigham and Women's Hospital Boston, Massachusetts, USA.
  • Stuckwisch AM; Brigham and Women's Hospital Boston, Massachusetts, USA.
  • Lipiner T; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Kittilson A; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Melberg M; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Gilbert RF; Brigham and Women's Hospital Boston, Massachusetts, USA.
  • Reynolds Z; Brigham and Women's Hospital Boston, Massachusetts, USA.
  • Iyer SL; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Chamberlin GC; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Vyas TD; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Vyas JM; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Goldberg MB; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Luban J; Harvard Medical School, Boston, Massachusetts, USA.
  • Li JZ; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Barczak AK; Broad Institute, Cambridge, Massachusetts, USA.
  • Lemieux JE; Harvard Medical School, Boston, Massachusetts, USA.
JCI Insight ; 7(19)2022 10 10.
Artículo en Inglés | MEDLINE | ID: covidwho-2064378
ABSTRACT
Protective immunity against SARS-CoV-2 infection after COVID-19 vaccination may differ by variant. We enrolled vaccinated (n = 39) and unvaccinated (n = 11) individuals with acute, symptomatic SARS-CoV-2 Delta or Omicron infection and performed SARS-CoV-2 viral load quantification, whole-genome sequencing, and variant-specific antibody characterization at the time of acute illness and convalescence. Viral load at the time of infection was inversely correlated with antibody binding and neutralizing antibody responses. Across all variants tested, convalescent neutralization titers in unvaccinated individuals were markedly lower than in vaccinated individuals. Increases in antibody titers and neutralizing activity occurred at convalescence in a variant-specific manner. For example, among individuals infected with the Delta variant, neutralizing antibody responses were weakest against BA.2, whereas infection with Omicron BA.1 variant generated a broader response against all tested variants, including BA.2.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacunas contra el SIDA / Vacunas contra el SIDAS / Vacunas contra Virus Sincitial Respiratorio / Vacunas contra Papillomavirus / COVID-19 Tópicos: Vacunas / Variantes Límite: Humanos Idioma: Inglés Año: 2022 Tipo del documento: Artículo País de afiliación: Jci.insight.159944

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacunas contra el SIDA / Vacunas contra el SIDAS / Vacunas contra Virus Sincitial Respiratorio / Vacunas contra Papillomavirus / COVID-19 Tópicos: Vacunas / Variantes Límite: Humanos Idioma: Inglés Año: 2022 Tipo del documento: Artículo País de afiliación: Jci.insight.159944